<DOC>
	<DOCNO>NCT01689610</DOCNO>
	<brief_summary>The purpose non-interventional study collect data efficacy safety Nab-Paclitaxel routine application .</brief_summary>
	<brief_title>Non-interventional Study With Nab-Paclitaxel ( Abraxane® )</brief_title>
	<detailed_description>The main focus non-interventional study set answer follow question : - Can result observe controlled clinical trial regard efficacy safety reproduce routine clinical setting ? - Are side-effects nab-paclitaxel therapy observe study comparable previously describe safety-profile term frequency intensity ? - What main reason modification termination nab-paclitaxel therapy ? - How nab-paclitaxel therapy influence patient ' quality life ? - What criteria select nab-paclitaxel therapy metastatic breast cancer ?</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Female Patients metastatic breast cancer , least 18 year old ( upper age limit ) Contraindication accord summary product characteristic Abraxane® No sign patient inform consent form available pregnant breastfeeding patient .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Nab-Paclitaxel</keyword>
	<keyword>Abraxane</keyword>
	<keyword>Nabucco</keyword>
	<keyword>safety</keyword>
	<keyword>breast cancer</keyword>
	<keyword>daily routine</keyword>
	<keyword>peripheral neuropathy</keyword>
	<keyword>iOMEDICO</keyword>
</DOC>